Sort
25,944 grants matching “neurodegeneration”
Characterizing new genes that govern mitochondrial function in the axon
$231,000Marc R Freeman · Oregon Health & Science University · R21 · FY2016 · NS
Targeting Specific ASIC Subunits and Heteromers Using Protein Engineering
$231,000David Malcom Maclean · University Of Rochester · R21 · FY2025 · NS
Conserved Aging Mechanisms Impacting Dopamine Neuron Survival
$231,000Ian Martin · Oregon Health & Science University · R21 · FY2022 · AG
Transcriptome analysis of glia responding to injury
$231,000Mary Allison Logan · Oregon Health & Science University · R21 · FY2013 · NS
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
$231,000Jacob Raber · Oregon Health & Science University · R21 · FY2023 · AG
Proteomic and Functional Analyses of Astrocyte Exosomes
$230,988Stephen J Crocker · University Of Connecticut Sch Of Med/Dnt · R21 · FY2015 · NS
Insights into Amyloid Pathogenicity Dynamics
$230,940Jeffrey Nicholas Savas · Northwestern University At Chicago · R21 · FY2023 · AG
Deciphering the tau phosphorylation code
$230,920Daniel T Pak · Georgetown University · R21 · FY2021 · AG
FUNCTION OF BCL-W IN MURINE DEVELOPMENT
$230,871Emory University · R01 · FY2000 · HD
Neurovascular frataxin and cognitive dysfunction in sickle cell disease
$230,830Rimi Hazra · University Of Pittsburgh At Pittsburgh · R21 · FY2023 · NS
MITOCHONDRIAL GENE SEQUENCE AND MUTATION IN PD
$230,794University Of Virginia Charlottesville · P50 · FY2000 · NS
LRRK2 and mitochondrial dysfunction
$230,790Xiongwei Zhu · Case Western Reserve University · R21 · FY2011 · NS
Regulation of Ionotropic Glutamate Receptors
$230,784Steven J Tavalin · University Of Tennessee Health Sci Ctr · R01 · FY2006 · NS
Role of circadian clocks in maintaining a healthy nervous system
$230,755Jadwiga M Giebultowicz · Oregon State University · R21 · FY2011 · NS
Gene Environment Interactions in Parkinson's Disease
$230,750Kim Tieu · University Of Rochester · R21 · FY2009 · ES
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION
$230,705University Of Kentucky · P01 · FY2001 · AG
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION
$230,705University Of Kentucky · P01 · FY2002 · AG
Mechanistic insight into RNA-mediated toxicity of C9orf72-linked ALS/FTD
$230,618Gary J Bassell · Emory University · R21 · FY2019 · NS
A Novel RNA Binding Protein Modulates Tau Pathology
$230,618Anita H Corbett · Emory University · R21 · FY2018 · AG
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIAS
$230,589Bradley T Hyman · Massachusetts General Hospital · P50 · FY2006 · AG
Training in Pharmacological Sciences
$230,530Erika A Bach · New York University School Of Medicine · T32 · FY2016 · GM
MECHANISM OF ESTROGEN NEUROPROTECTION IN ALZHEIMERS DISE
$230,525University Of Southern California · R01 · FY2001 · AG
c9RAN proteins as a biomarker for C9ORF72-associated ALS and FTD
$230,374Tania France Gendron · Mayo Clinic Jacksonville · R21 · FY2014 · NS
Novel Method for Alzheimer's Disease Drug Discovery
$230,363Dwight C. German · Ut Southwestern Medical Center · R21 · FY2009 · AG
Core D: Neuropathology Core
$230,300Ann Carolyn McKee · Boston University Medical Campus · P30 · FY2017 · AG